Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

RTTNews | 971 дней спустя
Hoth Therapeutics Partners Altasciences For Manufacturing HT-TBI For Traumatic Brain Injury/Stroke

(RTTNews) - Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Tuesday that it has signed an agreement with Altasciences, a fully integrated early phase CRO/CDMO, to develop and manufacture the HT-TBI drug product formulation.

HT-TBI is being developed as a novel, point-of-care therapy for the treatment and/or prevention of secondary brain injury resulting from ischemic stroke and traumatic brain injury (TBI).

HT-TBI will be developed as a ready-to-use drug-device combination product for use in non-healthcare settings by patients and caregivers at risk for stroke/TBI, emergency healthcare professionals, and military personnel.

The HT-TBI formulation development and manufacturing work by Altasciences will be used to support a future Investigational New Drug (IND) Application to initiate clinical trials.

For More Such Health News, visit rttnews.com

Тэгов: HOTH
read more
Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Hoth Therapeutics' Pre-IND Submission For HT-KIT For Advance Systemic Mastocytosis Accepted By FDA

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Monday it has submitted a request for a Pre-Investigational New Drug (IND) meeting to the U.S. Food and Drug Administration (FDA) to discuss the proposed drug development program for HT-KIT, a new molecular entity, for the treatment of advance systemic mastocytosis (AdvSM), a rare aggressive form of cancer.
RTTNews | 615 дней спустя
Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

Hoth Therapeutics Says FDA Accepts IND Application For HT-001 For Treatment Of Cancer Disorders

Biopharmaceutical company Hoth Therapeutics, Inc. (HOTH) announced Thursday that the U.S. Food and Drug Administration (FDA) has accepted an Investigational New Drug (IND) application for the company's HT-001 therapeutic for the treatment for rash and skin disorders associated with epidermal growth factor receptor (EGFR) inhibitor therapy.
RTTNews | 871 дней спустя
Sensex, Nifty Seen Lower On US Debt Concerns

Sensex, Nifty Seen Lower On US Debt Concerns

Indian shares look set to open lower on Monday as investors fret about the changing geo-political landscape in India's neighborhood as a new bonhomie between Bangladesh, China and Pakistan takes shape silently.
RTTNews | 4 минут назад
Thai Bourse May Reclaim 1,200-Point Plateau

Thai Bourse May Reclaim 1,200-Point Plateau

The Thai stock market has alternated between positive and negative finishes through the last eight trading days since the end of the five-day winning streak in which it had advanced more than 50 points or 4.3 percent. The Stock Exchange of Thailand now sits just above the 1,195-point plateau and it's expected to open to the upside again on Monday.
RTTNews | 45 минут назад
Japanese Market Notably Lower

Japanese Market Notably Lower

The Japanese stock market is trading notably lower on Monday, extending the losses in the previous three sessions, despite the broadly positive cues from Wall Street on Friday, with the Nikkei 225 falling below the 37,600 level, with a mixed performance across most sectors.
RTTNews | 1ч 9мин назад
Win Streak May Continue For Indonesia Stock Market

Win Streak May Continue For Indonesia Stock Market

The Indonesia stock market has finished higher in four straight sessions, improving more than 275 points or 4 percent in that span. The Jakarta Composite Index now rests just above the 7,100-point plateau and it's expected to extend its gains again on Monday.
RTTNews | 1ч 15мин назад
Hong Kong Bourse May Find Traction On Monday

Hong Kong Bourse May Find Traction On Monday

The Hong Kong stock market has moved lower in two straight sessions, dropping almost 300 points or 1.3 percent along the way. The Hang Seng Index now sits just beneath the 23,350-point plateau although it's due for support on Monday.
RTTNews | 1ч 30мин назад